Researcher.Life Logo

Current Opinion in Endocrinology, Diabetes and Obesity : Impact Factor & More

eISSN: 1752-2978pISSN: 1752-296X

Key Metrics

CiteScore
4.8
H-Index
78
Impact Factor
< 5
SJR
Q2Endocrinology
SNIP
1.35
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Opinion in Endocrinology, Diabetes and Obesity

Current Opinion in Endocrinology, Diabetes and Obesity Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Opinion in Endocrinology, Diabetes and Obesity ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Opinion in Endocrinology, Diabetes and Obesity

Exploring the role of parathyroid hormone in sarcopenia: A review.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
EDITORIAL INTRODUCTION.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
Editorial introduction.
  • 1 Jun 2026
  • Current opinion in endocrinology, diabetes, and obesity
Prediabetes before pregnancy: implications for risk stratification and research.
  • 20 May 2026
  • Current opinion in endocrinology, diabetes, and obesity
Exploring the role of parathyroid hormone in sarcopenia: A review.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
EDITORIAL INTRODUCTION.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
Parathyroid hormone assays in 2026: second versus third generation, standardization, and clinical interpretation.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.
  • 1 Aug 2026
  • Current opinion in endocrinology, diabetes, and obesity
Editorial introduction.
  • 1 Jun 2026
  • Current opinion in endocrinology, diabetes, and obesity
Prediabetes before pregnancy: implications for risk stratification and research.
  • 20 May 2026
  • Current opinion in endocrinology, diabetes, and obesity

FAQs on Current Opinion in Endocrinology, Diabetes and Obesity